May Lab

Chronic Liver Disease and Hepatocellular Carcinoma

Although overall cancer incidence and mortality have steadily declined in the United States over the past 15 years, liver cancer incidence and mortality have been on the rise. Ethnic minority groups experience a disproportionate burden of chronic liver disease and liver cancer.

The May Laboratory focuses on developing clinical pathways to identify patients who are at risk for chronic liver disease and liver cancer. Radiographic and clinical lab information available in electronic medical records is used along with population risk data based on race, gender and age in an automated process to predict the likelihood of liver disease and liver disease progression.

Our liver disease research leverages population health, health disparities, clinical medicine, machine learning, and metabolomics to enhance risk prediction, provide insights regarding liver cancer oncogenesis and inform a precision-health approach to managing at-risk patients in the clinical setting.

Chronic Liver Disease and Hepatocellular Carcinoma Research Team Photos

Collaborators

  • Yvonne Flores, PhD, Professor, Health Equity
  • Roshan Bastani, PhD, Professor, Health Policy and Management
  • Beth Glenn, PhD, Associate Professor, Health Policy and Management
  • Arpan A. Patel, MD, PhD, Assistant Clinical Professor of Medicine

Grants

  1. David Geffen School of Medicine Impact Grant; “Liver Cancer Prevention and Control - Understanding and Addressing Disparities” (Co-I)

Publications - Full list of May Lab publications(Link is external)